|
|
Value of Serum 14-3-3η Protein and anti-CCP Antibody in Diagnosis of Rheumatoid Arthritis |
WANG Jun-zhe, ZHANG Xiao-rong |
Clinical Laboratory Chongqing Three Gorges Central Hospital Chongqing Three Gorges 404000 |
|
|
Abstract 【Objective】To explore the diagnostic value of serum 14-3-3ηprotein and anti-cyclic citrullinated peptide (CCP) in rheumatoid arthritis (RA). 【Methods】A total of 40 patients with RA admitted to our hospital were selected as RA group, while 40 healthy persons who underwent physical examination in our hospital during the same period were selected as control group. In addition, 40 patients with non-RA joint disease were selected as non-RA joint disease group. Serum 14-3-3ηprotein, ES,CR,RF and anti-CCP antibody levels were detected in all three groups, and ROC curve was drawn to analyze their diagnostic value for RA. According to the degree of disease activity, RA patients were divided into active group and remission group. Serum 14-3-3 ηprotein and anti-CCP antibody levels were compared between the RA active and remission groups. The ROC curve was drawn to analyze the predictive value on the activity of RA. The area under the curve was obtained, the optimal cutoff value was defined, and the corresponding sensitivity and specificity were calculated. 【Results】Serum levels of 14-3-3ηprotein, anti-CCP antibody, ESR, CRP and RF in the RA group were significantly higher than those in the non-RA group and the control group (P<0.05).The areas under the curve of 14-3-3ηprotein, anti-CCP antibody and 14-3-3ηprotein combined with anti-CCP antibody in the diagnosis of RA were 0.666, 0.712 and 0.781, respectively. Among 40 patients with RA, 25 cases(62.50%) had active phase and 15 cases(37.50%)had remission phase. The levels of 14-3-3ηprotein and anti-CCP antibody in the RA active group were significantly higher than those in RA remission group (P<0.05).The area under the curve of 14-3-3ηprotein, anti-CCP antibody and 14-3-3ηprotein combined with anti-CCP antibody to predict the activity of RA was 0.733, 0.745 and 0.819, respectively. 【Conclusion】Serum 14-3-3ηprotein and anti-CCP antibody have certain value in the diagnosis of RA and the evaluation of disease activity. If necessary, they can be combined for better diagnosis of RA to improve the diagnostic coincidence rate.
|
Received: 24 June 2019
|
|
|
|
|
[1] Burmester GR, Pope JE. Novel treatment strategies in rheumatoid arthritis[J].Lancet,2017, 389(10086):2338-2348.
[2] Mcinnes IB.Pathogenetic insights from the treatment of rheumatoid arthritis[J].Lancet,2017, 389(10086):2328-2337.
[3] 肖雪野. 抗CCP抗体、补体及免疫球蛋白在类风湿性关节炎病理过程中的变化及临床意义[J].海南医学院学报, 2017, 23(4):514-517.
[4] 曾婷婷,谭立明,田永建等.14-3-3η对类风湿关节炎的诊断价值及其与骨代谢的相关性分析[J].解放军医学杂志,2018, 43(8):680-684.
[5] 中华医学会风湿病学分会. 类风湿关节炎诊断及治疗指南[J].中华风湿病学杂志, 2010, 14(4):265-270.
[6] Noack M, Miossec P. Selected cytokine pathways in rheumatoid arthritis[J].Semin Immunopathol,2017, 39(4):365-383.
[7] 何睿妍.血清14-3-3η蛋白在类风湿关节炎及骨关节炎患者血清的表达及临床意义[J].解剖科学进展, 2018, 24(1):84-87.
[8] 赵万辉, 王泽筠, 亓琳,等. 抗CCP抗体和抗MCV抗体等多种检测对类风湿性关节炎的诊断价值[J].检验医学, 2017, 32(11):975-978.
[9] 马方伟, 刘敏, 孙燕玲, 等.血清RF与抗-CCP抗体浓度指标在类风湿关节炎患者诊断和治疗中的临床价值[J].昆明医科大学学报,2017, 38(5):120-124.
[10] 孙佳颖, 王鑫, 谢科杰, 等. RF、抗CCP抗体、抗APF抗体、抗AKA抗体、抗MCV抗体联合检测诊断类风湿关节炎的价值[J].浙江医学, 2017, 39(21):1891-1894.
|
|
|
|